MAIA Biotechnology, Inc. — Form 8-K
Filed October 6, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
MAIA Biotechnology filed an 8-K on October 6, 2026 disclosing information under Regulation FD (Item 7.01) and including financial statements/exhibits (Item 9.01). The filing contains 43 documents including an exhibit with 28 graphics but the specific content, dollar amounts, counterparties, and nature of the disclosure are not readable from the document index provided.
Why this rating
Filing structure only visible; substantive disclosure content unavailable in index. Cannot assess materiality without knowing deal/news specifics.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from October 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.